Announcements - OBI Pharma 台灣浩鼎

2024.Aug.07

OBI receives US FDA Orphan Drug Designation for OBI-992 TROP2 ADC for the treatment of gastric cancer

2024.Aug.02

Announcement of change of accounting officer

2024.Aug.02

Announcement of change of acting spokesperson

2024.Aug.02

Announcement of new appointment of Chief Operating Officer

2024.Aug.02

Announcement of adjustment of an item in the plan of 2018 cash capital increase

2024.Aug.02

Announcement of BOD’s resolution to issue common shares through cash capital increase in 2024

2024.Aug.02

Announcement of the Consolidated Financial Statements for the second quarter of 2024 were approved by the Board of Directors.

2024.Jul.23

Announcement of the Company’s board meeting date to approve 2024Q2 consolidated financial report

2024.Jun.19

Announcement on behalf of OBIGEN that the Company’s Board of Directors resolved to appoint Mr. Frank Chen as Chairperson

2024.Jun.19

Announcement on behalf of OBIGEN of resolution to lift the non-competition restrictions for new directors

News

Latest news

Events

Latest events